Bruton type agammaglobulinemia

A hereditary immunodeficiency due to the failure of B-LYMPHOCYTES to mature and rearrangement failure of IG HEAVY CHAINS. Mutations in Agammaglobulinaemia tyrosine kinase (BTK gene) can cause X-linked AGAMMAGLOBULINEMIA type 1 (XLA). OMIM: 300755

Also Known As:

Agammaglobulinemia, BTK; Agammaglobulinemia, Bruton tyrosine kinase; Agammaglobulinemia, X-Linked; Agammaglobulinemia, X-Linked, Type I; Bruton's Agammaglobulinemia; Bruton-Type Agammaglobulinemia; Bruton-type (congenital X-linked) agammaglobulinemia; Congenital Agammaglobulinemia; Immunodeficiency 1; X-linked agammaglobulinemia

Hemic and Lymphatic Diseases: 6
- Hematologic Diseases: 3366
  - Blood Protein Disorders: 17
    - Agammaglobulinemia: 1550
      - Bruton type agammaglobulinemia: 533
- Lymphatic Diseases: 92
  - Lymphoproliferative Disorders: 4250
    - Agammaglobulinemia: 1550
      - Bruton type agammaglobulinemia: 533
Immune System Diseases: 4321
- Immunologic Deficiency Syndromes: 91
  - Agammaglobulinemia: 1550
    - Bruton type agammaglobulinemia: 533
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - X-Linked Genetic Diseases: 42
    - Bruton type agammaglobulinemia: 533

Misaki Kawase Selected Research

Misaki Kawase Research Topics

Disease

Drug/Important Bio-Agent (IBA)